Recombinant Topoisomerase II alpha anticorps (AA 1431-1531)

N° du produit ABIN7870710

L’anticorps anti-Topoisomerase II alpha Monoclonal Lapin est utilisé pour la détection de Topoisomerase II alpha dans des échantillons de Humain et Chien. Il a été validé pour IHC (p).

Aperçu rapide pour Recombinant Topoisomerase II alpha anticorps (AA 1431-1531) (ABIN7870710)

Antigène: Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain, Chien

Hôte: Lapin

Clonalité: Monoclonal

Conjugué: Cet anticorp Topoisomerase II alpha est non-conjugé

Application: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Classe de qualité: Carrier-free

Clone: TOP2A-7169R

Détail du produit anti-Topoisomerase II alpha anticorps

Épitope: AA 1431-1531

Fonction: Topoisomerase II alpha Antibody / TOP2A (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: A recombinant partial protein sequence (within amino acids 1431-1531) from the human protein was used as the immunogen for the Topoisomerase II alpha antibody.

Isotype: IgG, kappa

Information d'application

Indications d'application: Optimal dilution of the Topoisomerase II alpha antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the Topoisomerase II alpha antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur Topoisomerase II alpha

Antigène: Topoisomerase II alpha (TOP2A) (Topoisomerase (DNA) II alpha 170kDa (TOP2A))

Autre désignation: Topoisomerase II alpha

Sujet: The topoisomerase II-Alpha isoform is a 170 kDa nuclear protein and plays an important role in DNA synthesis and RNA transcription, as well as chromosomal segregation during mitosis. Topoisomerase II-Alpha is reported to be a sensitive and specific marker of late S-, G2- & M-phases in transformed and developmentally regulated normal cells, and has been shown to be over-expressed in many human cancers. Decreased expression of Topoisomerase II-Alpha is the predominant mechanism of resistance to several chemotherapeutic agents.

UniProt: P11388

Pathways: Cycle Cellulaire, Mitotic G1-G1/S Phases